RxDoctor Payments Data

Keith Hornbrook

Family · Auburn, NYNPI 1023784436

Payments from drug & device makers

$2,764in general payments, 2019–2025

Across 119 payments — averaging $23.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$476
  • Novo Nordisk$253
  • Collegium Pharmaceutical, Inc.$229
  • AstraZeneca$206
  • Lilly USA, LLC$192
  • AbbVie$175
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$2,764100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,764 in reported general payments places this provider in the 85th percentile of 8,883 family providers in New York.

See all family providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter54$38,967
TrulicityDulaglutide41$36,690
EliquisApixaban43$28,855
RybelsusSemaglutide13$25,823
JardianceEmpagliflozin23$18,437
OzempicSemaglutide13$12,727
JanuviaSitagliptin Phosphate17$12,313
XareltoRivaroxaban17$9,518
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,306
Citalopram HbrCitalopram Hydrobromide20$1,850
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate12$1,837
Albuterol Sulfate HfaAlbuterol Sulfate87$1,795
Gabapentin112$1,352
Atorvastatin Calcium171$1,271
Losartan Potassium175$1,093

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$144$38,96754 claims
Novo NordiskRybelsus, Ozempic$253$38,55026 claims
Lilly USA, LLCTrulicity$192$36,69041 claims
PfizerEliquis$116$28,85543 claims
Boehringer IngelheimJardiance$147$18,43723 claims
MerckJanuvia$48$12,31317 claims
Johnson & JohnsonXarelto$102$9,51817 claims
AstraZenecaBreztri Aerosphere$206$7,30612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,883 family providers in New York.

Other family in Auburn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →